MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma

  • Authors:
    • Hui Xu
    • Yan-Wei Hu
    • Jia-Yi Zhao
    • Xiu-Mei Hu
    • Shu-Fen Li
    • Yan‑Chao Wang
    • Ji-Juan Gao
    • Yan-Hua Sha
    • Chun-Min Kang
    • Li Lin
    • Chuan Huang
    • Jing-Jing Zhao
    • Lei Zheng
    • Qian Wang
  • View Affiliations

  • Published online on: May 7, 2015     https://doi.org/10.3892/or.2015.3957
  • Pages: 175-182
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide. PHD finger protein 19 (PHF19) encodes a member of the polycomb group (PcG) of proteins that functions by maintaining the repressive transcriptional states of many developmental regulatory genes. In addition, it has been shown that miR-195 plays an important role in the molecular etiology of HCC; however, the effect and possible mechanism of PHF19 on HCC is unclear, and the association between PHF19 and miR-195 has seldom been addressed. In the present study, we investigated the carcinogenic activity and mechanism of PHF19 on HCC in vivo and in vitro. Our results showed that PHF19 is a potential target of hsa-miR-195-5p based on a bioinformatic analysis and results of a luciferase reporter assay. PHF19 was downregulated after transfection with hsa-miR-195-5p mimics. Moreover, we demonstrated that overexpression of PHF19 promoted hepatoma cell migration, invasion and proliferation in vitro. In contrast, overexpression of hsa-miR-195-5p in hepatoma cells reduced PHF19 expression, leading to suppression of hepatoma cell invasion, migration and proliferation in vitro. In addition, PHF19 markedly promoted the growth of xenograft tumors, while hsa-miR-195-5p markedly suppressed the growth of xenograft tumors in nude mice. These results provide evidence that PHF19 promotes HCC and is regulated by the tumor‑suppressor, miR-195-5p.
View Figures
View References

Related Articles

Journal Cover

July-2015
Volume 34 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu H, Hu Y, Zhao J, Hu X, Li S, Wang YC, Gao J, Sha Y, Kang C, Lin L, Lin L, et al: MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma. Oncol Rep 34: 175-182, 2015
APA
Xu, H., Hu, Y., Zhao, J., Hu, X., Li, S., Wang, Y. ... Wang, Q. (2015). MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma. Oncology Reports, 34, 175-182. https://doi.org/10.3892/or.2015.3957
MLA
Xu, H., Hu, Y., Zhao, J., Hu, X., Li, S., Wang, Y., Gao, J., Sha, Y., Kang, C., Lin, L., Huang, C., Zhao, J., Zheng, L., Wang, Q."MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma". Oncology Reports 34.1 (2015): 175-182.
Chicago
Xu, H., Hu, Y., Zhao, J., Hu, X., Li, S., Wang, Y., Gao, J., Sha, Y., Kang, C., Lin, L., Huang, C., Zhao, J., Zheng, L., Wang, Q."MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma". Oncology Reports 34, no. 1 (2015): 175-182. https://doi.org/10.3892/or.2015.3957